mind, it is no wonder why some of the largest malpractice losses stem from breast augmentation revision surgery. 4 Standard techniques to correct rippling and thin coverage include changing to silicone gel implants or converting to a submuscular plane, but often there is still not enough coverage. Fat injection has been advocated to correct skin surface irregularities, but this can result in induration, calcifications, cysts, infection, and lumpy irregularities. 5 Capsulotomy or capsulectomy with insertion of a new implant is often performed to address CC, but these techniques are not the panacea. Placement of a fresh implant in a new plane-subpectoral, neopectoral, 6 or dual-planehas been touted as another solution to this difficult problem. Different variations of capsulorrhaphy and implant pocket changes have been employed to correct implant malposition as well. Despite there being a number of options, all these techniques fail at times and leave the plastic surgeon frustrated by an undesirable result.
An alternative method that has been described is the placement of acellular dermal matrix (ADM) to create a new implant pocket or mask surface irregularities. Animal studies have demonstrated that ADM prevents even postradiation CC. 7, 8 These products have been utilized extensively in the realm of breast reconstruction with some evidence that they reduce CC in humans, but this point remains controversial. Based on initial research support, ADM products have more recently been presented as an adjunct to the aforementioned techniques for difficult cosmetic breast revisions. Strattice (Lifecell Corp, Branchburg, New Jersey), a porcine ADM (PADM) product, may have particular promise for cosmetic breast surgery. It has less stretch, with the theoretical ability to provide more long-lasting support, and is more cost-effective than most other products. This latter point is often of particular concern for the cosmetic patient who is paying for her procedure without insurance coverage. In this study, we review our experience using PADM to enhance the outcomes of difficult revision breast augmentation surgery.
MEthOds
A retrospective chart review was conducted on all patients who had undergone cosmetic breast surgery with PADM in our practice between May 2009 and September 2012. All cases were "fee for service," with patients paying costs for surgery, anesthesia, operating room, implants, and PADM. Reconstructive procedures and cases that involved other ADM products were excluded. All 93 remaining consecutive patients (179 breasts) were operated on by 1 surgeon (J.N.P.). Data were analyzed for product use description and complications, including infection, extrusion, CC, and implant malposition.
The techniques employed were similar to those for breast reconstruction. For contour defects and rippling, the ADM was fenestrated to allow for egress of fluid and was secured deep to the affected cutaneous area to provide smooth soft tissue coverage. For breast support or implant malposition, the ADM was secured in place with 2-0 Vicryl sutures (Ethicon, Inc, Somerville, New Jersey) in a slinglike fashion (Figure 1 ). To recreate the inframammary fold (IMF), the implant was completely covered by securing the ADM between the pectoralis major muscle and the desired IMF location.
Drains were left in place in all cases until drainage was less than 20 mL in a 24-hour period. Patients' dressings were individualized to the complication that was treated. Malposition patients received foam tape for approximately 2 weeks and were then placed into a full-coverage underwire bra for approximately 8 weeks.
REsuLts
Average patient age was 42 years (range, 23-70 years). The mean follow-up period was 17 months (range, 1-39 months); 65% of patients in this series had a follow-up of more than 1 year. Preoperatively, there were 36 patients with CC ( Figure 2 ), 22 with bottoming out or stretch Figure 1 . Intraoperative view of acellular dermal matrix being placed superficial to the implant to support the inferior portion. It is secured medially, laterally, and to the inframammary fold with 2-0 Vicryl. It is then sutured to the inferior border of the pectoralis major muscle for complete implant coverage. (Table 1) . Some patients in this series carried multiple diagnoses and therefore required multiple corrective procedures. In this series, we performed 73 capsulectomies, 38 capsulorrhaphies, 29 pocket conversions, and 50 mastopexies ( Figure 6 ).
There were 2 major postrevision complications (1.6% of breasts). One was an infection in 1 breast requiring explantation 2 weeks postoperatively. The PADM was partially incorporated and part was removed; the wound culture later grew methicillin-resistant Staphylococcus aureus (MRSA). The patient was treated with antibiotics, the infection resolved, and the patient underwent successful reaugmentation at a later date. A second patient who underwent mastopexy augmentation developed PADM extrusion along the vertical limb of her mastopexy. The PADM was removed and the wound was closed. The same patient developed swelling along the contralateral vertical limb and the PADM was removed prophylactically. She healed without incident. Five patients (5.3%) required revision mastopexy to correct minor imperfections due to early skin stretch recurrence. Three patients required raising of the IMF and 1 patient required lowering. Two patients received small volumes of fat graft for minor contour correction. One patient went to another physician after augmentation with Strattice to exchange her implants for a larger size. One of her implants subsequently extruded, at which point she returned to our office for explantation and augmentation revision with PADM. She has experienced no other problems since then. One patient had early tightening; she developed a minor hematoma after capsulectomy and required drainage. She subsequently moved and was lost to follow-up but may have had recurrence of her CC. To date, there was no other CC recurrence in any of the patients who underwent capsulectomy with Strattice placement in this series.
disCussiOn
Multiple ADM products have been used in breast reconstruction, but surgeons only recently have begun to explore their uses in cosmetic breast surgery. Maxwell and Gabriel 9 published a case series of 78 revision breast augmentations with various ADM products, with the only complications being 1 hematoma and 1 malposition. Most important, there were no Baker III/IV contractures at 1 year. Hartzell et al 10 later published their work on 38 cases with AlloDerm (Lifecell Corp). In that cohort, there was 1 infection and 2 persistent surface irregularities. Most recently, Spear at al 11 reviewed their experience with multiple ADM products in 77 patients, 56% of whom underwent cosmetic procedures. Their complications were also infrequent, with 1.3% having bottoming-out, 1.3% having a major infection, and 1.3% having ripple recurrence.
Similar to previous reports, results from our series demonstrated a high success rate with few complications. The single infection is consistent with long-term data for primary breast augmentation, recently reported to have an infection rate of 1.8%. 12 There were 4 minor revision mastopexies performed that were deemed necessary to correct small amounts of skin stretch or mild asymmetries. Many of the patients presented with extreme asymmetry and were told that minor touch-ups might be necessary.
Porcine ADM is easy to use as it comes in both sheets and precontoured shapes. Although we utilized small pieces of PADM in many of the early cases, we began to utilize large sheets with the "contour" shape for all of the more recent cases in late 2010, when they became commercially available. The latter were deemed most appropriate for inferior support and fold malpositions.
One concern that arises regarding these products is seroma formation. Although not all authors agree, only 1 of 4 comparative studies has demonstrated a statistically significant increase in infection and seroma rate in the ADM group. 13 Chun et al 13 reported a seroma rate of 9.7% in the ADM group versus only 3.0% in the control group after excluding all native skin flap necrosis cases. Considering the conflicting evidence, drains were used in all cases to prevent seroma formation.
Another objection that is often raised regarding the use of ADM for cosmetic surgery is that they are expensive when accounting for product cost, surgeon fee, and anesthesia expenses. If long-term data indicate that the revision rate of cosmetic breast surgery is dramatically decreased, however, the use of ADM for revisions and possibly even primary augmentation cases may save patients time and money. Unfortunately, only 61 patients from our series had a follow-up of 1 year or longer at the time this report was written, but we look forward to continuing to evaluate our results critically over time.
COnCLusiOns
Porcine ADM demonstrated great utility as an adjunct in revisionary cosmetic breast surgery. The product helped to provide good aesthetic outcomes with low complication rates. Prospective, randomized trials may prove helpful in defining the role of PADM further in these challenging cases.
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